Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-FES PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer: a Phase II Prospective Cohort Study Evaluating the Performance of FES PET/MRI in Axillary Staging Compared With Axillary Surgery

NCT05982496 is registered in ClinicalTrials.gov with Università Vita-Salute San Raffaele as lead sponsor.

NCT NCT05982496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05982496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-FES PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer: a Phase II Prospective Cohort Study Evaluating the Performance of FES PET/MRI in Axillary Staging Compared With Axillary Surgery
Lead sponsor
Università Vita-Salute San Raffaele
Phase
Phase 2
Overall status
Recruiting
Start date
June 9, 2026
Completion date
December 1, 2029
Enrollment
119 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

axillary lymphadenopathy, breast cancer female, lobular breast carcinoma, luminal a breast cancer, pet/mri